Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)
Phase of Trial: Phase III
Latest Information Update: 17 May 2017
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections; Pregnancy
- Focus Registrational; Therapeutic Use
- Sponsors Biotest AG
- 01 Apr 2017 Status changed from recruiting to completed.
- 30 Mar 2017 This trial has been completed in Italy.
- 11 Mar 2017 This trial has been completed in Belgium as per European Clinical Trials Database record.